Brazil's state research agency is growing chicken meat from cells — and the world's top beef exporter says it's just the beginning

Brazil is the world's largest beef exporter — a country built, in large part, on cattle. So when its own federal research agency starts growing meat in a dish, without a single animal slaughtered, it's a signal that the idea has moved well past the experimental fringe.

That's exactly what's happening at Embrapa, Brazil's state agricultural research corporation. Researchers there have produced prototype chicken-breast fillets grown from cultured cells — a small biopsy taken from a living animal, multiplied in a nutrient-rich liquid, then shaped on tiny scaffolds into three-dimensional muscle tissue.

Two labs, one technology package

The work is split between two sites: Embrapa Swine and Poultry, based in Concórdia, Santa Catarina, and the Nanobiotechnology Laboratory (LNANO) at Embrapa Genetic Resources and Biotechnology — known as Cenargen — in Brasília. According to a report by Agência Brasil published June 14, 2026, the experiments use cells multiplied in a controlled environment with nutrients, oxygen, glucose, amino acids, and mineral salts.

Biologist Luciano Paulino da Silva, the researcher coordinating the cultivated meat experiments at LNANO, told Agência Brasil that the prototype should be finalized in 2027. He frames the project in plain commercial terms: once the technology package is ready, private companies will be able to license the methods to make and sell specific products.

"Até meados do ano que vem, vai estar na vitrine como um ativo tecnológico Embrapa." ("By around the middle of next year, it will be on display as an Embrapa technological asset.")

— Luciano Paulino da Silva, researcher, Embrapa LNANO

Why a state lab, and why now

The appeal is partly environmental. Traditional cattle farming drives deforestation and releases large amounts of methane, so meat grown in a lab promises a far lighter footprint. But there's also a strategic logic: by developing the know-how in-house, Brazil positions itself to help shape an industry that Singapore, the United States, Israel, and Australia are already racing to lead — several of which have already granted regulatory or commercial approval.

Brazil set its own regulatory groundwork early. ANVISA, the national health surveillance agency, published RDC No. 839 in 2023, establishing a framework for cultivated meat years before the first commercial product is expected to reach a Brazilian shelf.

Beyond chicken fillets

Embrapa's cultivated meat work isn't limited to poultry. Reporting from Agência Brasil indicates the lab has also tested prototypes including salmon, caviar, and squid rings, alongside research into an edible film that could function as casing for sausage products made with cultivated meat technique — a potential replacement for traditional animal-derived casings.

The lab's work has already been published in a peer-reviewed scientific journal, and several large Brazilian food groups and startups now run their own cultivated-meat research units, signaling that Embrapa's public investment is feeding a wider domestic ecosystem rather than competing alone.

What's still ahead

Despite the scientific progress, Embrapa is careful to frame this as still experimental. The research should not be confused with a ready product on supermarket shelves. The real challenge now is transforming lab prototypes into industrial processes that meet cost, safety, scale, and consumer-acceptance requirements simultaneously — the same bottleneck that has slowed cultivated meat companies worldwide, even in markets with full regulatory approval like Singapore and the United States.

For FuturoFood's readers across the region, the story matters less for what's on the menu today and more for what it signals: Latin America's largest agricultural economy is choosing to build cultivated-protein capability domestically, in a public lab, rather than simply importing the technology once it matures elsewhere.